Cargando…

Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization

BACKGROUND: Glioblastoma (GB) is the most common and highly malignant brain tumor characterized by aggressive growth and resistance to alkylating chemotherapy. Autophagy induction is one of the hallmark effects of anti-GB therapies with temozolomide (TMZ). However, the non-classical form of autophag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Niu, Qin, Zhou, Hong, Li, Qing-Rui, Lin, Yong, Liang, Mei, Li, Si-Si, Ping, Yi-Fang, Liu, Xin-Dong, Bian, Xiu-Wu, Yao, Xiao-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862393/ https://www.ncbi.nlm.nih.gov/pubmed/35193644 http://dx.doi.org/10.1186/s13046-022-02291-8

Ejemplares similares

Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation
por: Dong, Lei, et al.
Publicado: (2022)

Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021)

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
por: Cai, Hong-Qing, et al.
Publicado: (2020)

Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma
por: Gao, Xiang-Yu, et al.
Publicado: (2021)

Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide
por: Quann, Kevin, et al.
Publicado: (2013)

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
por: Wen, Zhi-peng, et al.
Publicado: (2019)

MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
por: Zhao, Chengbin, et al.
Publicado: (2020)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

MicroRNA-30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin 1 and inhibiting autophagy
por: Xu, Jing, et al.
Publicado: (2018)

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival
por: Rahman, Mohummad Aminur, et al.
Publicado: (2019)

The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression
por: Yuan, Ye, et al.
Publicado: (2022)

Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury
por: Fan, Hong, et al.
Publicado: (2020)

Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
por: Xu, Ningbo, et al.
Publicado: (2018)

MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin
por: Qian, Chunfa, et al.
Publicado: (2019)

The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin
por: Wang, Xi‐wen, et al.
Publicado: (2021)

Thioredoxin VdTrx1, an unconventional secreted protein, is a virulence factor in Verticillium dahliae
por: Tian, Li, et al.
Publicado: (2023)

MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression
por: Wu, YiHan, et al.
Publicado: (2019)

Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial
por: Du, Xiao-Jing, et al.
Publicado: (2019)

Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
por: Zhang, Xiao-Ning, et al.
Publicado: (2021)

Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
por: Zhang, Fang, et al.
Publicado: (2014)

A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation
por: Zhou, HuiTing, et al.
Publicado: (2014)

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
por: Yang, Eryan, et al.
Publicado: (2022)

Necroptosis-mediated HMGB1 secretion of keratinocytes as a key step for inflammation development in contact hypersensitivity
por: Lian, Ni, et al.
Publicado: (2022)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

The HMGB1 signaling pathway activates the inflammatory response in Schwann cells
por: Man, Li-li, et al.
Publicado: (2015)

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema
por: Hong, Bangxing, et al.
Publicado: (2018)

SS-1 Therapeutic challenges for glioblastoma: Temozolomide and its issues?
por: Nagane, Motoo
Publicado: (2020)

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide
por: Wang, Nan, et al.
Publicado: (2021)

Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
por: Pandey, Arvind, et al.
Publicado: (2021)

Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA‐101 in glioblastoma
por: Cai, Tao, et al.
Publicado: (2018)

Posttranslational S-nitrosylation modification regulates HMGB1 secretion and promotes its proinflammatory and neurodegenerative effects
por: Yang, Ru, et al.
Publicado: (2022)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis
por: Shi, Zhong-Fang, et al.
Publicado: (2023)

Expression pattern of HMGB1 and its association with autophagy in acute necrotizing pancreatitis
por: Yu, Can, et al.
Publicado: (2016)

1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages
por: Rao, Zebing, et al.
Publicado: (2017)

Interplay of m(6)A and histone modifications contributes to temozolomide resistance in glioblastoma
por: Li, Fuxi, et al.
Publicado: (2021)

Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
por: Gao, Yong-tao, et al.
Publicado: (2016)

The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
por: Zhang, Yuan, et al.
Publicado: (2009)

Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma
por: Zhang, Ge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4oslhtn0afkhc0lj1385fe5ipe